Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

The market faces challenges such as high costs of sophisticated devices and rural preference for traditional methods, but ...

Explore how GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are impacting obesity rates in America, while also highlighting ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.

In Nigeria, a silent health crisis is unfolding mdash;diabetes, once thought to be an adult disease, is increasingly ...